Evommune Ownership | Who Owns Evommune?
Evommune Ownership Summary
Evommune is owned by 92.72% institutional investors, 2.77% insiders, and 4.51% retail investors. Eqt fund management s.a r.l. is the largest institutional shareholder, holding 14.63% of EVMN shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 3.33% of its assets in Evommune shares.
EVMN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Evommune | 92.72% | 2.77% | 4.51% |
| Sector | Healthcare Stocks | 128.69% | 12.02% | -40.72% |
| Industry | Biotech Stocks | 180.58% | 11.62% | -92.20% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Eqt fund management s.a r.l. | 5.29M | 14.63% | $43.68M |
| Ra capital management | 3.49M | 11.09% | $80.34M |
| Pivotal bioventure partners investment advisor | 1.93M | 5.33% | $15.92M |
| Rtw investments, lp | 1.50M | 4.77% | $34.54M |
| Nan fung group | 1.44M | 3.99% | $11.90M |
| Price t rowe associates inc /md/ | 1.12M | 3.55% | $25.73M |
| Blackrock funding, inc. /de | 1.15M | 3.19% | $9.53M |
| Janus henderson group | 896.70K | 2.84% | $20.62M |
| Vanguard capital management | 1.00M | 2.78% | $8.30M |
| Baker bros. advisors lp | 847.39K | 2.69% | $19.48M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nan fung group | 1.44M | 7.95% | $11.90M |
| Velan capital investment management lp | 446.25K | 6.43% | $10.26M |
| Pivotal bioventure partners investment advisor | 1.93M | 6.32% | $15.92M |
| Eqt fund management s.a r.l. | 5.29M | 4.61% | $43.68M |
| Great point partners | 325.00K | 1.72% | $7.47M |
| Ra capital management | 3.49M | 0.85% | $80.34M |
| Silverarc capital management | 594.03K | 0.57% | $4.91M |
| Andera partners | 97.36K | 0.46% | $804.21K |
| Nextbio capital management lp | 119.06K | 0.42% | $983.46K |
| Rtw investments, lp | 1.50M | 0.34% | $34.54M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 896.70K | 0.01% | 896.70K |
| Baker bros. advisors lp | 847.39K | 0.11% | 847.39K |
| Alyeska investment group | 726.36K | 0.05% | 726.36K |
| Qube research | 684.71K | 0.00% | 654.60K |
| Silverarc capital management | 594.03K | 0.57% | 594.03K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jpmorgan chase | 40.06K | - | -1.51M |
| Bioimpact capital | - | - | -1.46M |
| Andera partners | 97.36K | 0.46% | -1.29M |
| Eventide asset management | - | - | -1.21M |
| Kynam capital management, lp | - | - | -625.50K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Janus henderson group | 896.70K | 0.01% | 896.70K | $20.62M |
| Baker bros. advisors lp | 847.39K | 0.11% | 847.39K | $19.48M |
| Alyeska investment group | 726.36K | 0.05% | 726.36K | $16.70M |
| Silverarc capital management | 594.03K | 0.57% | 594.03K | $4.91M |
| Freestone grove partners lp | 337.29K | 0.05% | 337.29K | $7.75M |
Sold Out
| Holder | Change |
|---|---|
| Royal bank of canada | -585.00 |
| Plante moran financial advisors | -1.15K |
| Strs ohio | -1.80K |
| Mitsubishi ufj kokusai asset management | -1.80K |
| National bank of canada /fi/ | -2.40K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 107 | -7.76% | 33,505,075 | -3.50% | 92 | 1.00% | 68 | -16.05% | 24 | 84.62% |
| Jun 30, 2026 | 116 | 38.10% | 34,862,516 | 0.83% | 96 | 0.91% | 81 | 28.57% | 13 | 18.18% |
| Mar 31, 2026 | 81 | 37.29% | 34,361,905 | 26.33% | 109 | 1.46% | 61 | 3.39% | 11 | - |
| Dec 31, 2025 | 59 | - | 27,200,904 | - | 86 | - | 59 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 1.21M | 3.33% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 739.07K | 2.05% | 452.27K |
| Vanguard Total Stock Mkt Idx Inv | 739.07K | 2.05% | 452.27K |
| Vanguard MStar Total Stk Mkt Idx Invest | 739.07K | 2.04% | - |
| US Small-Cap Growth II Equity Comp | 614.72K | 1.71% | 251.99K |
| RTW Biotech Opportunities Ord | 600.24K | 1.65% | 600.24K |
| American Century U.S. Small Cap Growth | 567.83K | 1.58% | 190.57K |
| American Century Small Cap Growth Inv | 567.83K | 1.56% | - |
| iShares Russell 2000 ETF | 379.52K | 1.05% | - |
| T. Rowe Price New Horizons | 373.10K | 1.03% | -186.75K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 08, 2026 | Carver Kyle | Chief Financial Officer | Buy | $13.26K |
| Jul 07, 2026 | KIRSCH ARTHUR S | - | Buy | $133.00K |
| Jun 22, 2026 | Drew Janice Suzann | Chief of Dev. Operations | Sell | $452.60K |
| Jun 22, 2026 | Patel Jeegar Pravinkumar | Chief Scientific Officer | Sell | $33.48K |
| Jun 22, 2026 | Pena Luis C. | President & CEO | Sell | $168.92K |
EVMN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools